Viatris Inc (VTRS): M&A transaction — Viatris closes €1.95B divestiture of over-the-counter business to Cooper Consumer Health

On July 3, 2024, Viatris Inc., a Delaware corporation (“ Viatris ” or the “ Company ”), closed the previously announced transaction with Cooper Consumer Health SAS, a French corporation (“ Cooper Consumer Health ”), involving the divestiture by Viatris of substantially all of Viatris’ over-the-counter products business (the “ Business ”) and related assets and liabilities (the “ Transaction ”), to Cooper Consumer Health and certain of its affiliates (collectively, the “ Buyer Parties ”), in exchange for consideration from the Buyer Parties of up to €1,950.0 million in cash on a cash-free, debt-free basis, consisting of (a) €1,850.0 million in cash consideration at closing, subject to certain adjustments as set forth in the Transaction Agreement (defined below), including for net indebtedness and net working capital, and (b) up to €100.0 million in contingent additional cash consideration, which shall be payable by the Buyer Parties to Viatris following closing if the shareholders of th